Cutler Group LP Agenus Inc Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$1.96 - $3.14 $17,444 - $27,946	-8,900 Reduced 98.03%	179 $0
Q2 2022 Aug 04, 2022	SELL	$1.3 - $2.64 $2,057 - $4,179	-1,583 Reduced 14.85%	9,079 $17,000
Q1 2022 Apr 14, 2022	BUY	$2.35 - $3.47 $9,266 - $13,682	3,943 Added 58.68%	10,662 $26,000
Q4 2021 Jan 18, 2022	SELL	$2.92 - $5.74 $14,308 - $28,126	-4,900 Reduced 42.17%	6,719 $21,000
Q3 2021 Oct 26, 2021	BUY	$4.98 - $6.63 $57,768 - $76,908	11,600 Added 61052.63%	11,619 $60,000
Q2 2021 Jul 19, 2021	BUY	$2.56 - $5.49 $48 - $104	19 New	19 $0

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.